(Q44397077)

English

Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study

scientific article published in July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study (English)

1 reference

Europe PubMed Central

2 December 2017

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

Yaakov Naparstek

4

object named as

Yaakov Naparstek

1 reference

Europe PubMed Central

2 December 2017

author name string

Alon Y Hershko

1

1 reference

Europe PubMed Central

2 December 2017

Anat Scheiman-Elazari

2

1 reference

Europe PubMed Central

2 December 2017

Suhail Aamar

3

1 reference

Europe PubMed Central

2 December 2017

publication date

1 July 2013

1 reference

Europe PubMed Central

2 December 2017

Immunologic Research

1 reference

Europe PubMed Central

2 December 2017

56

1 reference

Europe PubMed Central

2 December 2017

2-3

1 reference

Europe PubMed Central

2 December 2017

376-381

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1007/s12026-013-8412-0

0 references

Treatment of proliferative lupus nephritis: a slowly changing landscape

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Autoantibodies in lupus: culprits or passive bystanders?

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Removal of pathogenic autoantibodies by immunoadsorption

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Epidemiology and management of refractory lupus nephritis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Refractory disease in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Microscopic polyangiitis: Clinical presentation

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Recombinant human Dnase I (rhDNase) in patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8412-0

21 January 2018

Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Theoretical basis of pathogenic substance removal during plasmapheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with a laminin-derived peptide suppresses lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of systemic lupus erythematosus with LJP 394.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating anti-DNA immune complexes in active lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo clearance and tissue uptake of an anti-DNA monoclonal antibody and its complexes with DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23584986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12026-013-8412-0

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44397077&oldid=2020976634"